Alexander Y. Tokman - 21 Jan 2026 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Y. Tokman by Mark Busch, attorney-in- fact
Issuer symbol
NDRA
Transactions as of
21 Jan 2026
Net transactions value
$0
Form type
4
Filing time
23 Jan 2026, 19:42:44 UTC
Previous filing
23 Feb 2024
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tokman Alexander Y Chief Executive Officer, Director C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR /s/ Alexander Y. Tokman by Mark Busch, attorney-in- fact 23 Jan 2026 0001334483

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Award $0 +75,000 +1500000% $0.000000 75,005 21 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027.